Hjem › Melanom › Connecticut › New Haven
Kliniske studier for Melanom i New Haven, CT
10 studier for Melanom søker deltakere på steder i og rundt New Haven (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- Yale Cancer Center, New Haven
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
RekruttererFase 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
- og 1 flere
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RekruttererFase 3
- Yale Cancer Center, New Haven
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RekruttererFase 1/2
- Yale University, New Haven
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Yale University, New Haven
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
RekruttererFase 1/2
- Yale School of Medicine, North Haven · 7 mi unna
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
RekruttererFase 1/2
- Yale University, New Haven
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- Yale University, New Haven
- Smilow Hospital Care Center, Guilford, Guilford · 13 mi unna
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
RekruttererFase 1/2
- Yale Cancer Center, New Haven
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
RekruttererFase 2
- Yale, New Haven
Melanom-studier i andre byer
- Houston, TX59 studier
- New York City, NY38 studier
- Los Angeles, CA34 studier
- Nashville, TN33 studier
- Pittsburgh, PA31 studier
- Boston, MA26 studier
- Philadelphia, PA23 studier
- San Francisco, CA22 studier
- Atlanta, GA21 studier
- Durham, NC21 studier
- St. Louis, MO21 studier
- Columbus, OH21 studier
Andre studier i New Haven
- Ikke-småcellet lungekreft41 studier
- Brystkreft37 studier
- Kreft (alle typer)33 studier
- Metastatisk kreft23 studier
- Lungekreft22 studier
- Plateepitelcancer i hode og hals22 studier
- Eggstokkreft21 studier
- Kolorektal kreft20 studier
- Prostatakreft20 studier
- Opioidoverdose18 studier
- Alkoholbrukforstyrrelse (AUD)17 studier
- Akut myelogen leukemi17 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.